SciencesTimes

Canada AR and VR spending is estimated near US$1.97B in 2026, growing about 16.4 per cent a year. A segment-by-segment look at therapy, training, e-learning and hardware, and why...

The Galleri multi-cancer blood test is now sold in Canada for about $2,099. Where to get it, what it can and cannot detect, and why no provincial plan covers...

From mRNA vaccines to targeted chemotherapy and in-body gene editing, nanoparticles are reshaping modern medicine. Here is how these microscopic carriers work and what comes next.

Climate change is one of the most pressing issues facing our planet today, with far-reaching consequences for ecosystems and biodiversity. As global...

The largest trial of the Galleri multi-cancer early detection blood test just reported. Here is what it found, what it misses, and how it is reaching Canada.

The same drugs transforming obesity and diabetes care are leaving some patients with an unexpected complaint: thinning hair. As GLP-1…

Sucking CO2 Out of Thin Air Is No Longer Science Fiction The Intergovernmental Panel on Climate Change has been clear:…

Breaking the Silicon Ceiling Silicon solar cells have dominated the market for decades, but they are approaching a hard physical…

The First Patients Are Typing With Their Thoughts In January 2024, Neuralink implanted its N1 chip in a human patient…

Close to a dozen cultivated meat approvals worldwide, and still no commercial-scale sales. Where each jurisdiction stands, why Health Canada has published nothing, and why regulation was never the...